Document Detail

The management of acute pulmonary arterial hypertension.
MedLine Citation:
PMID:  20560976     Owner:  NLM     Status:  In-Data-Review    
Acute pulmonary arterial hypertension (PAH), which may complicate the course of many complex disorders, is always underdiagnosed and its treatment frequently begins only after serious complications have developed. Acute PAH is distinctive because they differ in their clinical presentation, diagnostic findings, and response to treatment from chronic PAH. The acute PAH may take either the form of acute onset of chronic PAH or acute PAH or surgery-related PAH. Significant pathophysiologic differences existed between acute and chronic PAH. Therapy of acute PAH should generally be aimed at acutely relieving right ventricular (RV) pressure overload and preventing RV dysfunction. There are three classes of drugs targeting the correction of abnormalities in endothelial dysfunction, which have been approved recently for the treatment of PAH: (1) prostanoids; (2) endothelin receptor antagonists; and (3) phosphodiesterase-5 inhibitors. The efficacy and safety of these compounds have been confirmed in uncontrolled studies in patients with PAH. Intravenous epoprostenol is suggested to serve as the first-line treatment for the most severe patients. In the other situations, the first-line therapy may include bosentan, sildenafil, or a prostacyclin analogue. Recent advances in the management of PAH have markedly improved prognosis.
Gan Hui-Li
Related Documents :
16160596 - Effects of nicorandil on monocrotaline-induced pulmonary arterial hypertension in rats.
2116616 - Experience with long-term nifedipine therapy in paediatric cardiological patients.
1554866 - The rat is a poor animal model for the study of human pulmonary hypertension.
7704246 - Pulmonary vasculitis with hypereosinophilia and episodic pulmonary hypertension: report...
18089426 - Splenic artery steal syndrome in living donor liver transplantation: a case report.
17563096 - Closure of unroofed coronary sinus with a covered stent in a symptomatic infant.
Publication Detail:
Type:  Journal Article     Date:  2010-06-18
Journal Detail:
Title:  Cardiovascular therapeutics     Volume:  29     ISSN:  1755-5922     ISO Abbreviation:  Cardiovasc Ther     Publication Date:  2011 Jun 
Date Detail:
Created Date:  2011-05-13     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101319630     Medline TA:  Cardiovasc Ther     Country:  England    
Other Details:
Languages:  eng     Pagination:  153-75     Citation Subset:  IM    
Copyright Information:
© 2010 Blackwell Publishing Ltd.
Cardiac Surgery Department, Beijing Anzhen Hospital, Capital Medical University (BAZH-CMU), Beijing Institute of Heart, Lung, and Blood Vessel Disease, Beijing 100029, China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Mechanistic insights into acquired drug resistance in epidermal growth factor receptor mutation-targ...
Next Document:  Mycobacterial lipoprotein activates autophagy via TLR2/1/CD14 and a functional vitamin D receptor si...